Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients

Neurological Research

Volumn 22, Issue 5, 2000, Pages 434-442

  Murase, S ^a   Saio, M ^a   Andoh, H ^a   Takenaka, K ^a   Shinoda, J ^a   Nishimura, Y ^a   Sakai, N ^a   Takami, T ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Primary central nervous systems lymphoma; Soluble CD27; Soluble interleukin 2 receptor; Tumor marker

Indexed keywords

CD27 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; CANCER DIAGNOSIS; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; LEUKOCYTE COUNT; MALE; RELAPSE; TUMOR REGRESSION;

EID: 0033855182     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.2000.11740697     Document Type: Article

References (25)

1. Expression of oncogenic molecules in primary central nervous system lymphomas in immunocompetent patients
2. Minimally invasive diagnosis of acquired immunodeficiency syndrome- related primary central nervous system lymphoma
3. Diagnosis of AIDS-related focal brain lesions: A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF
4. A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients
5. Multiplex PCR for diagnosis of AIDS-related central nervous system lymphoma and toxoplasmosis
6. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma
7. Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions
8. CD27-CD70 interactions regulate B-cell activation by T cells
9. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex
10. Expression and release of CD27 in human B-cell malignancies
11. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies
12. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure
13. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease
14. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
15. Two distinct antigen systems in human B lymphocytes: Indication of cell surface and intra cellular antigen using monoclonal antibodies
16. Soluble interleukin-2 receptor and macrophage colony-stimulating factor (M-CSF) in cerebro-spinal fluid in patients with hematological malignancies: Clinical significance in adult T-cell leukemia with meningeal infiltration
17. The influence of referral patterns on the characteristics of diagnostic tests
18. Primary central nervous system lymphomas in 72 immunocompetent patients: Pathologic findings and clinical correlations
19. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases
20. Pre-irradiation methotrexate chemotherapy of primary central nervous system lymphoma: Long-term outcome
21. Primary central nervous system lymphoma: Variety of clinical manifestations and survival
22. Successful treatment of primary central nervous system lymphoma with chemotherapy after osmotic blood-brain barrier opening
23. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic Vincristine-Doxorubicine-Cyclophosphamide- Prednisolone
24. Primary malignant lymphoma of the central nervous system: Results of treatment of 11 cases and review of the literature
25. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?